Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Manegold

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
Seminars in Oncology|June 1, 1997
A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancerU Gatzemeier, C Manegold, W Eberhard, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2006
Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancerV Surmont, R J van Klaveren, C Goor, et al.
Onkologie|June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"U Räth, H Flechtner, J Selbach, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancerJ P Braybrooke, M Ranson, C Manegold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancerPhilipp C Manegold, Carmen Paringer, Ulrike Kulka, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 22, 2012
Imaging of tumor viability in lung cancer: initial results using 23Na-MRIT Henzler, S Konstandin, G Schmid-Bindert, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyV Trillet-Lenoir, J Green, C Manegold, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
British Journal of Cancer|April 28, 2006
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancerG V Scagliotti, A Szczesna, R Ramlau, et al.
Circulation|March 17, 1999
Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplastyC Manegold, M Alwazzeh, H Jablonowski, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Seminars in Oncology|June 1, 1997
A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancerU Gatzemeier, C Manegold, W Eberhard, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2006
Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancerV Surmont, R J van Klaveren, C Goor, et al.
Onkologie|June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"U Räth, H Flechtner, J Selbach, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancerJ P Braybrooke, M Ranson, C Manegold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancerPhilipp C Manegold, Carmen Paringer, Ulrike Kulka, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 22, 2012
Imaging of tumor viability in lung cancer: initial results using 23Na-MRIT Henzler, S Konstandin, G Schmid-Bindert, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyV Trillet-Lenoir, J Green, C Manegold, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
British Journal of Cancer|April 28, 2006
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancerG V Scagliotti, A Szczesna, R Ramlau, et al.
Circulation|March 17, 1999
Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplastyC Manegold, M Alwazzeh, H Jablonowski, et al.
Pageof 18